Firms
Theme

CROX

Crocs, Inc. · NASDAQ

News

12 latest

Zacks Investment Research

Crocs (CROX) Registers a Bigger Fall Than the Market: Important Facts to Note

Crocs stock fell 1.43% on October 23, 2026, underperforming the broader market. The company is set to report earnings on October 29 with expected EPS of $3.31 (up 13.36% YoY) and revenue of $1 billion (up 0.87% YoY). Despite recent underperformance, Crocs holds a Zacks Rank #2 (Buy) rating and trades at a discount with a Forward P/E of 8.66 compared to its industry average of 16.76.

Zacks Investment Research

Crocs (CROX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Crocs is expected to report Q3 2026 earnings of $3.31 per share (up 13.4% YoY) with revenues of $1 billion (up 0.9% YoY) on October 29. With a positive Earnings ESP of +0.60% and Zacks Rank #2 (Buy), the company is positioned as a likely earnings-beat candidate. Crocs has beaten consensus EPS estimates in all four of the last quarters.

Zacks Investment Research

Why Crocs (CROX) is Poised to Beat Earnings Estimates Again

Crocs (CROX) is highlighted as a stock well-positioned to continue its earnings-beat streak. The company has beaten earnings estimates in its previous two quarters with an average surprise of 6.44%. With a positive Earnings ESP of +0.60% and a Zacks Rank #2 (Buy), analysts suggest another earnings beat is likely when the company reports on October 29, 2026.

Zacks Investment Research

CROX vs. CTAS: Which Stock Is the Better Value Option?

A comparison of Crocs (CROX) and Cintas (CTAS) in the Textile-Apparel sector reveals that Crocs offers superior value for investors. CROX has a Zacks Rank of #2 (Buy) with a forward P/E of 8.60 and Value grade of B, while CTAS holds a Zacks Rank of #3 (Hold) with a forward P/E of 38.35 and Value grade of F. Based on valuation metrics and earnings outlook improvements, CROX is identified as the better value option.

Zacks Investment Research

Crocs (CROX) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Crocs stock declined 1.23% on October 16, 2026, underperforming the S&P 500's 1.09% loss. The company is expected to report Q3 earnings on October 29 with EPS of $3.3 (up 13.01% YoY) and revenue of $1 billion (up 0.72% YoY). Despite solid earnings growth projections, Crocs holds a Zacks Rank #3 (Hold) rating and trades at a Forward P/E of 8.94, below its industry average of 16.44.

Zacks Investment Research

Crocs' Brand Strength and Product Innovation to Bolster Growth

Crocs (CROX) is expanding beyond its iconic clogs through new product categories, designer collaborations, and enhanced digital engagement. The company is strengthening e-commerce, international reach, and operational efficiency to drive growth while managing cost pressures and competition. CROX trades at a forward P/E of 7.92X versus the industry average of 15.26X, with consensus estimates showing 11.5% EPS growth in 2026.

Zacks Investment Research

Crocs (CROX) Advances While Market Declines: Some Information for Investors

Crocs stock rose 1.48% to $116.68, outperforming the broader market decline. The company is expected to report Q3 earnings on October 29, 2026, with anticipated EPS of $3.3 (up 13.01% YoY) and quarterly revenue of $1 billion. CROX holds a Zacks Rank #3 (Hold) with a Forward P/E of 8.24, trading at a discount to its industry average.

Zacks Investment Research

Crocs' International Growth Accelerates: Can It Lead 2026?

Crocs (CROX) raised its 2026 brand revenue growth outlook to 2%-3% from flat to 2%, driven by strong international performance. Q2 saw 7% international revenue growth with double-digit gains in China, India, and Japan, while the company opened 160 new stores globally. Despite positive international momentum, CROX carries a Zacks Rank #4 (Sell) and trades at a lower valuation than peers.

Zacks Investment Research

Crocs (CROX) Surpasses Market Returns: Some Facts Worth Knowing

Crocs (CROX) closed at $120.33, up 1.81%, outperforming the S&P 500's 0.58% gain. The company is expected to report EPS of $3.3 (up 13.01% YoY) with revenue projected at $1 billion. However, Crocs carries a Zacks Rank #4 (Sell) rating despite trading at a Forward P/E of 8.47, below the industry average of 15.12, and a PEG ratio of 0.99.

Zacks Investment Research

Why Crocs (CROX) is a Top Momentum Stock for the Long-Term

Zacks Premium offers investment research tools including Style Scores (Value, Growth, Momentum, and VGM) designed to complement the Zacks Rank system. The Style Scores rate stocks A-F based on valuation, growth prospects, and price momentum to help investors identify securities with the highest probability of outperforming the market over 30 days. Crocs (CROX) is highlighted as a stock to watch with a #3 Hold rank and B VGM Score, showing strong momentum with shares up 1.6% over four weeks.

Mentions CROX

Zacks Investment Research

GIL Falls 11.1% in One Month as Retail Risks Test the Recovery Case

Gildan Activewear (GIL) shares declined 11.1% in four weeks as weak retail demand and HanesBrands integration execution risks weigh on investor sentiment. Despite raising 2026 adjusted EPS guidance to $4.65-$4.75 and operating margin forecast to 21.8%, the company's $4.7 billion net debt and 3.2X leverage remain concerns. The stock trades at a discount valuation but faces headwinds from retail softness and elevated acquisition-related costs.

Zacks Investment Research

Is GIL Stock a Buy as Low Valuation Meets HanesBrands Execution Risk?

Gildan Activewear (GIL) has fallen 22.7% in 12 weeks and trades at a steep valuation discount of 8.0X forward earnings versus the industry's 15.3X. While the HanesBrands integration promises $100 million in 2026 synergies and earnings growth to $4.67 per share, the company faces significant headwinds including $4.7 billion in net debt, elevated leverage, and soft retail demand. The stock's upside potential depends on successful execution of integration targets and debt reduction, but current risks favor a cautious stance.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $CROX · 0 threads

Sign in to post on $CROX

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev